Dialysis catheter-related bacteremia: Treatment and prophylaxis

American Journal of Kidney Diseases

Volumn 44, Issue 5, 2004, Pages 779-791

  Allon, Michael ^a,b  

^a University of Alabama at Birmingham   (United States)

^b Division of Nephrology   (United States)

Author keywords

antibiotic; bacteremia; catheter; infection; Vascular access

Indexed keywords

2 PROPANOL; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BACITRACIN; CEFAZOLIN; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; CITRATE TRISODIUM; CITRIC ACID; GENTAMICIN; GRAMICIDIN; HEPARIN; LINEZOLID; OXYCHLOROSENE; POLYMYXIN B; POLYSPORIN; PSEUDOMONIC ACID; RIFAMPICIN; TAUROLIDINE; VANCOMYCIN;

BACTEREMIA; BACTERIAL COLONIZATION; BIOFILM; BLOOD CULTURE; CANDIDA; CATHETER INFECTION; CHILL; CLINICAL PROTOCOL; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DIALYSIS; DRUG EFFICACY; ECONOMIC ASPECT; ENTEROCOCCUS; ERADICATION THERAPY; FEMORAL VEIN; FEVER; FREQUENCY ANALYSIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GUIDE WIRE; HEMODIALYSIS PATIENT; HUMAN; HYPOCALCEMIA; INFECTION PREVENTION; INTERMETHOD COMPARISON; INTRAVENOUS CATHETER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; OTOTOXICITY; PARENTERAL NUTRITION; PERIPHERAL VEIN; REVIEW; RISK FACTOR; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; GENTAMICINS; HUMANS; MUPIROCIN; RENAL DIALYSIS; TAURINE; THIADIAZINES;

EID: 7444265772     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.07.005     Document Type: Review

References (66)

1. S.J. Schwab, G.A. Beathard The hemodialysis catheter conundrum Hate living with them, but can't live without them Kidney Int 56 1999 1 17
2. J.I. Tokars, E.R. Miller, M.J. Alter, M.J. Arduino National surveillance of dialysis-associated diseases in the United States, 2000 Semin Dial 15 2002 162 171
3. D. Reddan, P. Klassen, D.L. Frankenfield National profile of practice patterns for hemodialysis vascular access in the United States J Am Soc Nephrol 13 2002 2117 2124
4. R.L. Pisoni, E.W. Young, D.M. Dykstra Vascular access use in Europe and in the United States Results from the DOPPS Kidney Int 61 2002 305 316
5. B. Hoen, A. Paul-Dauphin, D. Hestin, M. Kessler EPIBACDIAL A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients J Am Soc Nephrol 9 1998 869 876
6. K.A. Marr, D.J. Sexton, P.J. Conlon, G.R. Corey, S.J. Schwab, K.B. Kirkland Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis Ann Intern Med 127 1997 275 280
7. B. Tanriover, D. Carlton, S. Saddekni Bacteremia associated with tunneled dialysis catheters Comparison of two treatment strategies Kidney Int 57 2000 2151 2155
8. Z. Krishnasami, D. Carlton, L. Bimbo Management of hemodialysis catheter related bacteremia with an adjunctive antibiotic lock solution Kidney Int 61 2002 1136 1142
9. S. Pastan, M. Soucie, W.M. McClellan Vascular access and increased risk of death among hemodialysis patients Kidney Int 62 2002 620 626
10. M. Allon, T.A. Depner, M. Radeva Impact of dialysis dose and membrane on infection-related hospitalization and death Results of the HEMO Study J Am Soc Nephrol 14 2003 1863 1870
11. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Vascular Access Update 2000 Am J Kidney Dis 37 suppl 1 2001 S137 S181
12. M. Allon, M.L. Robbin Increasing arteriovenous fistulas in hemodialysis patients Problems and solutions Kidney Int 62 2002 1109 1124
13. L. Troidle, T. Eisen, F.O. Finkelstein Why do so many patients have a dialysis catheter and not arteriovenous fistulae or grafts? 2004 Proceedings of the 24th Annual Dialysis Conference, San Antonio, TX, Feb 9-11, (abstr)
14. A. Vardhan, J. Davies, I. Daryanani, A. Crowe, P. McClelland Treatment of haemodialysis catheter-related infections Nephrol Dial Transplant 17 2002 1149 1150
15. C.V. Poole, D. Carlton, L. Bimbo, M. Allon Treatment of catheter-related bacteremia with an antibiotic lock protocol Effect of bacterial pathogen Nephrol Dial Transplant 19 2004 1237 1244
16. L.A. Mermel, B.M. Farr, R.J. Sherertz Guidelines for the management of intravascular catheter-related infections Clin Infect Dis 32 2001 1249 1272
17. J. DesJardin Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer Ann Intern Med 131 1999 641 647
18. G.K. Dogra, H. Herson, B. Hutchison Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate A randomized controlled study J Am Soc Nephrol 13 2002 2133 2139
19. S.J. Schwab, M.A. Weiss, F. Rushton Multicenter clinical trial results with the Lifesite hemodialysis access system Kidney Int 62 2002 1026 1033
20. C.E. Lok, K.E. Stanley, J.E. Hux, R. Richardson, S.W. Tobe, J. Conly Hemodialysis infection prevention with polysporin ointment J Am Soc Nephrol 13 2003 169 179
21. M.H. Mokrzycki, B. Schroppel, G. Von Gersdorff, H. Rush, M.P. Zdunek, R. Feingold Tunneled-cuffed catheter associated infections in hemodialysis patients who are seropositive for the human immunodeficiency virus J Am Soc Nephrol 11 2000 2122 2127
22. Centers for Disease Control and Prevention Staphylococcus aureus resistant to vancomycin--United States, 2002 MMWR Morb Mortal Wkly Rep 51 2002 565 567
23. L. Passerini, K. Lam, J.W. Costerton, E.G. King Biofilms on indwelling vascular catheters Crit Care Med 20 1992 665 673
24. J.W. Costerton, P.S. Stewart, E.P. Greenberg Bacterial biofilms A common cause of persistent infections Science 284 1999 1318 1322
25. R.M. Donlan Biofilm formation A clinically relevant microbiologic process Clin Infect Dis 33 2001 1387 1392
26. R.M. Donlan Biofilms Microbial life on surfaces Emerg Infect Dis 8 2002 881 890
27. R.D. Swartz, J.M. Messana, C.J. Boyer, N.M. Lunde, W.F. Weitzel, T.L. Hartman Successful use of cuffed central venous hemodialysis catheters inserted percutaneously J Am Soc Nephrol 4 1994 1719 1725
28. G.B. Lund, S.O. Trerotola, P.F. Scheel Outcome of tunneled hemodialysis catheters placed by radiologists Radiology 198 1996 467 472
29. T.F. Saad Bacteremia associated with tunneled, cuffed hemodialysis catheters Am J Kidney Dis 34 1999 1114 1124
30. T. Pourchez, P. Moriniere, A. Fournier, J. Pietri Use of Permcath (Quinton) catheter in uremic patients in whom the creation of conventional vascular access for hemodialysis is difficult Nephron 53 1989 297 302
31. B. Bastani, J. Minton, S. Islam Insufficient penetration of systemic vancomycin into the PermCath lumen Nephrol Dial Transplant 15 2000 1035 1037
32. G.A. Beathard Management of bacteremia associated with tunneled-cuffed hemodialysis catheters J Am Soc Nephrol 10 1999 1045 1049
33. D. Shaffer Catheter-related sepsis complicating long-term, tunneled central venous dialysis catheters Management by guidewire exchange Am J Kidney Dis 25 1995 593 596
34. D. Robinson, P. Suhocki, S.J. Schwab Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange Kidney Int 53 1998 1792 1794
35. T.U. Anthony, L.G. Rubin Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports) Antimicrob Agents Chemother 43 1999 2074 2076
36. Y. Haimi-Cohen, N. Husain, J. Meenan, G. Karayalcin, M. Lehrer, L.G. Rubin Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports Simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique Antimicrob Agents Chemother 45 2001 1565 1567
37. B. Messing, S. Peitra-Cohen, A. Debure, M. Beliah, J.J. Bernier Antibiotic-lock technique A new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients J Parenter Enteral Nutr 12 1988 185 189
38. S. Panagea, A. Galloway Intravascular-catheter-related infections Lancet 351 1998 1738 1739 (letter)
39. R. Boorgu, A.J. Dubrow, N.W. Levin Adjunctive antibiotic/anticoagulant lock therapy in the treatment of bacteremia associated with the use of a subcutaneously implanted hemodialysis access device ASAIO J 46 2000 767 770
40. J.B. Atkinson, K. Chamberlin, B.A. Boody A prospective randomized trial of urokinase as an adjuvant in the treatment of proven Hickman catheter sepsis J Pediatr Surg 33 1998 714 716
41. C. Dannenberg, U. Bierbach, A. Rothe, J. Beer, D. Korholz Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with Broviac catheters J Pediatr Hematol Oncol 25 2003 616 621
42. M.J. Oliver, S.M. Callery, K.E. Thorpe, S.J. Schwab, D.N. Churchill Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use A prospective study Kidney Int 58 2000 2543 2545
43. R.H. Flowers, K.J. Schwenzer, R.F. Kopel, M.J. Fisch, S.I. Tucker, B.M. Farr Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled trial JAMA 261 1989 878 883
44. J.F. Timsit, V. Sebille, J.C. Farkas Effect of subcutaneous tunneling on internal jugular catheter-related sepsis in critically ill patients A prospective, randomized multicenter study JAMA 276 1996 1416 1420
45. A.G. Randolph, D.J. Cook, C.A. Gonzales, C. Brun-Buisson Tunneling short-term central venous catheters to prevent catheter-related infection A meta-analysis of randomized, controlled trials Crit Care Med 26 1998 1452 1457
46. K.B. Stevenson, E.L. Hannah, C.A. Lowder Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data Predicting the impact of NKF-DOQI clinical practice guidelines for vascular access Am J Kidney Dis 39 2002 549 555
47. M.C. Weijmer, M.G. Vervloet, P.M. ter Wee Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use Nephrol Dial Transplant 19 2004 670 677
48. G.A. Beathard Catheter management protocol for catheter-related bacteremia prophylaxis Semin Dial 16 2003 403 405
49. D.W. Johnson, R. MacGinley, T.D. Kay A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters P: Nephrol Dial Transplant 17 2002 1802 1807
50. R.L. Hill, M.W. Casewell Nasal carriage of MRSA The role of mupirocin and outlook for resistance Drugs Exp Clin Res 16 1990 397 402
51. B.D. Cookson Mupirocin resistance in staphylococci J Antimicrob Chemother 25 1990 497 501
52. V.L. Yu, A. Goetz, M. Wagener Staphylococcus aureus nasal carriage and infection in patients on hemodialysis Efficacy of antibiotic prophylaxis N Engl J Med 315 1986 91 96
53. J.R. Boelaert, H.W. Van Landuyt, C.A. Godard Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients Nephrol Dial Transplant 8 1993 235 239
54. R. Bambauer, P. Mestres, K.J. Pirrung, P. Sloshansl Scanning electron microscopic investigation of catheters for blood access Artif Organs 18 1994 272 275
55. S.O. Trerotola, M.S. Johnson, H. Shah Tunneled hemodialysis catheters Use of a silver-coated catheter for prevention of infection--A randomized study Radiology 207 1998 491 496
56. R.O. Darouiche, I.I. Raad, S.O. Heard Catheter Study Group A comparison of two antimicrobial-impregnated central venous catheters N Engl J Med 340 1999 1 8
57. W.H. Traub, B. Leonhard, D. Bauer Taurolidine In vitro activity against multiple-antibiotic-resistant, nosocomially significant clinical isolates of Staphylococcus aureus, Enterococcus faecium, and diverse Enterobacteriaceae Chemotherapy 39 1993 322 330
58. C. Torres-Viera, C. Thauvin-Eliopoulos, M. Souli Activities of taurolidine in vitro and in experimental enterococcal endocarditis Antimicrob Agents Chemother 44 2000 1720 1724
59. M.C. Weijmer, Y.J. Debets-Ossenkopp, F.J. van der Vondervoort, P.M. ter Wee Superior antimicrobial activity of trisodium citrate over heparin for catheter locking Nephrol Dial Transplant 17 2002 2189 2195
60. C.B. Shah, M.W. Mittelman, J.W. Costerton Antimicrobial activity of a novel catheter lock solution Antimicrob Agents Chemother 46 2002 1674 1679
61. K.J. Henrickson, R.A. Axtell, S.M. Hoover Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution A randomized, multicenter, double-blind trial J Clin Oncol 18 2000 1269 1278
62. M. Allon Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution Clin Infect Dis 36 2003 1539 1544
63. M.G.H. Betjes, M. van Agteren Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution Nephrol Dial Transplant 19 2004 1546 1551
64. K. Sodemann, H.D. Polaschegg, B. Feldmer Two years' experience with Dialock and CLS (a new antimicrobial lock solution) Blood Purif 19 2001 251 254
65. M.C. Weijmer, A. Van den Dorpel, J.A.C.A. Van Geelen Substantial reduction of infectious complications in hemodialysis patients with trisodium citrate 30% as catheter locking solution A prospective multicenter double-blind randomised controlled trial J Am Soc Nephrol 14 2003 54A (abstr)
66. G.A. Beathard, G.A. Posen Initial clinical results with the LifeSite Hemodialysis Access System Kidney Int 58 2000 2021 2027